Microphonics, Inc. (MRPS) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMicrophonics, Inc. (MRPS) trades at $0.00003. Microphonics, Inc. specializes in ultrasound diagnostic equipment and speech recognition systems across diverse sectors. While the company caters to various markets, it operates within the OTC market, presenting unique investment considerations. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for MRPS: MRPS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Microphonics, Inc. (MRPS) Healthcare & Pipeline Overview
Microphonics, Inc. develops and markets ultrasound diagnostic equipment and speech recognition systems for industrial, manufacturing, governmental, agricultural, automotive, racing, and medical sectors. Based in Nashville, Tennessee, the company's technology is applied to acoustical ultrasound for mechanical diagnostic evaluations, operating within the broader healthcare and industrial diagnostics market.
What Is the Investment Thesis for MRPS?
Microphonics Inc. presents a unique investment proposition due to its diverse market applications in ultrasound diagnostics and speech recognition. Key value drivers include its established presence in niche markets such as automotive racing and industrial diagnostics. Growth catalysts involve potential expansion within the medical sector, leveraging its ultrasound technology for advanced diagnostic solutions. However, investors may want to evaluate the risks associated with the company's OTC market listing, including potential liquidity constraints and disclosure requirements. The company's ability to innovate and adapt its technology to emerging market needs will be crucial for sustained growth. Monitoring the company's financial disclosures and competitive positioning is essential for assessing its long-term viability.
Based on FMP financials and quantitative analysis
MRPS Key Highlights
Microphonics Inc. operates in the healthcare sector, specifically within medical diagnostics and research.
- The company develops, manufactures, and markets ultrasound diagnostic and detection equipment.
- Microphonics also offers speech recognition systems for various industries.
- The company serves diverse markets including industrial, manufacturing, governmental, agricultural, automotive, racing, and medical sectors.
- Microphonics Inc. is based in Nashville, Tennessee.
Who Are MRPS's Competitors?
MRPS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc. | $654.80 | +0.35% | $242B | 68 5-pillar |
| DHR Danaher Corporation | $214.06 | +1.09% | $150B | 68 5-pillar |
| NTRA Natera, Inc. | $410.35 | +0.46% | $58.8B | 38 5-pillar |
| A Agilent Technologies, Inc. | $167.77 | +0.65% | $47.4B | 84 5-pillar |
| IQV IQVIA Holdings Inc. | $258.21 | -0.96% | $42.5B | 73 5-pillar |
| WAT Waters Corporation | $425.21 | -0.08% | $41.8B | 64 5-pillar |
| ILMN Illumina, Inc. | $273.04 | +2.75% | $41.3B | 94 5-pillar |
| IDXX IDEXX Laboratories, Inc. | $518.39 | +0.12% | $40.9B | 92 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MRPS's Key Strengths?
Diverse market applications across multiple sectors.
- Specialized expertise in ultrasound and speech recognition technologies.
- Customization capabilities to meet specific client requirements.
- Established presence in niche markets such as automotive racing.
What Are MRPS's Weaknesses?
OTC market listing may limit liquidity and investor access.
- Limited financial information available due to OTC status.
- Potential shell risk associated with OTC-listed companies.
- Unknown disclosure status.
What Are the Key Risks for MRPS?
Competition from larger, more established companies in the medical diagnostics and speech recognition markets.
- Technological obsolescence in the rapidly evolving technology landscape.
- Economic downturns affecting customer demand across various sectors.
- Regulatory changes impacting the healthcare and industrial sectors.
- Risks associated with OTC market listing, including limited liquidity and disclosure.
What Are MRPS's Competitive Advantages?
- Specialized expertise in ultrasound and speech recognition technologies.
- Established presence in niche markets such as automotive racing.
- Diverse customer base across multiple sectors.
- Customization capabilities to meet specific client requirements.
What Does MRPS Do?
Microphonics Inc., based in Nashville, Tennessee, specializes in the development, manufacturing, and marketing of ultrasound diagnostic and detection equipment, alongside speech recognition systems. Founded with the vision of applying advanced acoustic technology across diverse sectors, the company has evolved to serve a wide array of markets including industrial, manufacturing, governmental, agricultural, automotive, professional racing, and medical fields. Its core offerings revolve around deploying ultrasound and electronic technology for acoustical ultrasound in mechanical diagnostic evaluations. Over the years, Microphonics has strategically positioned itself to cater to niche applications within these sectors. For instance, in the automotive and racing industries, its ultrasound technology is utilized for predictive maintenance and performance diagnostics. In the medical sector, the company provides specialized diagnostic tools. The company's speech recognition systems are tailored for environments ranging from manufacturing floors to governmental applications, emphasizing accuracy and reliability in challenging acoustic conditions. While specific founding details are not available, Microphonics has established itself as a provider of specialized diagnostic and detection solutions.
What Products and Services Does MRPS Offer?
- Develops ultrasound diagnostic equipment.
- Manufactures ultrasound detection equipment.
- Markets ultrasound diagnostic and detection equipment.
- Develops speech recognition systems.
- Markets speech recognition systems.
- Applies ultrasound technology for acoustical ultrasound.
- Performs mechanical diagnostic evaluations.
How Does MRPS Make Money?
- Sells ultrasound diagnostic and detection equipment to various industries.
- Generates revenue from the sale of speech recognition systems.
- Provides maintenance and support services for its equipment.
- Customizes its technology for specific client needs.
What Industry Does MRPS Operate In?
Microphonics Inc. operates within the medical diagnostics and research industry, a sector characterized by continuous technological advancements and increasing demand for precise and efficient diagnostic tools. The market is driven by factors such as an aging population, the rising prevalence of chronic diseases, and the growing adoption of advanced imaging techniques. Competitors range from large multinational corporations to smaller specialized firms. Microphonics differentiates itself by focusing on niche applications across diverse sectors, including industrial and automotive, in addition to healthcare. The company's ability to adapt its ultrasound and speech recognition technologies to specific market needs is a key factor in its competitive positioning.
Who Are MRPS's Key Customers?
- Industrial companies requiring diagnostic equipment.
- Manufacturing firms using speech recognition systems.
- Governmental agencies needing detection equipment.
- Medical facilities utilizing ultrasound diagnostic tools.
- Automotive and racing teams employing diagnostic systems.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Microphonics, Inc. operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in Nashville, US. The company is led by CEO Robert J. Lowers. MRPS has traded publicly since 1996.
MRPS Latest News
No recent news available for MRPS.
MRPS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MRPS.
Price Targets
Wall Street price target analysis for MRPS.
MRPS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MRPS; grades run from A+ (80-100) to F (below 30).
Leadership: Robert J. Lowers
CEO
Robert J. Lowers serves as the CEO of Microphonics, Inc. As CEO, he is responsible for the overall strategic direction and operational management of the company, guiding its activities in the development, manufacturing, and marketing of ultrasound diagnostic equipment and speech recognition systems.
Track Record: Details regarding Robert J. Lowers' specific achievements, strategic decisions, and company milestones under his leadership are not available. Assessing his track record requires further information on key performance indicators and strategic initiatives implemented during his tenure.
MRPS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may be subject to limited regulatory oversight and may not provide detailed financial information to the public. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like NYSE or NASDAQ, due to the potential for limited liquidity, transparency, and regulatory scrutiny.
- OTC Tier: OTC Other
- Limited liquidity due to OTC Other listing.
- Potential for price volatility due to low trading volume.
- Unknown disclosure status increases information asymmetry.
- Shell risk detected raises concerns about legitimacy.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive positioning.
- Evaluate the management team and their track record.
- Investigate any red flags or potential risks.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established history in ultrasound and speech recognition technologies.
- Diverse customer base across multiple sectors.
- Physical headquarters in Nashville, Tennessee.
- CEO listed as Robert J. Lowers.
- Focus on specialized diagnostic and detection solutions.
MRPS Healthcare Stock FAQ
What are the main risks for MRPS?
The main risks for Microphonics, Inc. include its OTC market listing, which carries inherent risks such as limited liquidity, potential price volatility, and reduced regulatory oversight.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available due to OTC status.
- OTC Other tier carries higher investment risk.